Transcriptional regulation of corticotrophin releasing factor gene by furocoumarins isolated from seeds of Psoralea corylifolia

Life Sciences

Volumn 82, Issue 21-22, 2008, Pages 1117-1121

  Chen, Yangchao ^a   Cheung, Yuen Ting ^a   Kong, Ling dong ^b   Ng, Tzi Bun ^a   Qiao, Chunfeng ^a   Mo, Shi fu ^a   Xu, Hong xi ^a   Kung, Hsiang fu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NANJING UNIVERSITY   (China)

Author keywords

Antidepressant drug; Corticotrophin releasing factor; Depression; Traditional Chinese medicine

Indexed keywords

ANGELICIN; ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; COUMARIN; FIREFLY LUCIFERASE; FORSKOLIN; FUROCOUMARIN DERIVATIVE; ISOPSORALENSIDE; LUCIFERASE; PSORALEN; PSORALENOSIDE; PSORALIDIN; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ASSAY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PLANT SEED; PSORALEA; PSORALEA CORYLIFOLIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CELL LINE; CELL SURVIVAL; CORTICOTROPIN-RELEASING HORMONE; FLUOXETINE; FORSKOLIN; GENE EXPRESSION REGULATION; MICE; PROMOTER REGIONS (GENETICS); PSORALEA; PSORALENS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEEDS; TETRAZOLIUM SALTS; THIAZOLES;

CULLEN CORYLIFOLIA; RENILLA LUCIFERASE;

EID: 43049136833     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.03.014     Document Type: Article

References (19)

1. Aubry J.M., Pozzzoli G., and Vale W.W. Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdale. Neuroscience Letters 266 (1999) 197-200
2. Basta-Kaim A., Budziszewska B., Jaworska-Feil L., Tetich M., Kubera M., Leskiewicz M., and Lason W. Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathway. Neuropharmacology 49 (2005) 156-164
3. Basta-Kaim A., Budziszewska B., Jaworska-Feil L., Tetich M., Kubera M., Leskiewicz M., Otczyk M., and Lason W. Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells- an involvement of protein kinases. Neuropsychopharmacology 31 (2006) 53-65
4. Budziszewska B., Jaworska-Feil L., Tetich M., Basta-Kaim A., Kubera M., Leskiewicz M., and Lason W. Regulation of the human corticotropin-releasing-hormone gene promoter activity by antidepressant drugs in Neuro-2A and AtT-20 cells. Neuropsychopharmacology 29 (2004) 785-794
5. Chen Y., Kong L.D., Xia X., Kung H.F., and Zhang L. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the forced swimming test in mice. Journal of Ethnopharmacology 96 (2005) 451-459
6. Erhardt A., Ising M., Unschuld P.G., Kern N., Lucae S., Putz B., Uhr M., Binder E.B., Holsboer F., and Keck M.E. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology 31 (2006) 2515-2522
7. Fadda P., Pani L., Porcella A., and Fratta W. Chronic imipramine, l-sulpiride and mianserine decrease corticotropin releasing factor levels in the rat brain. Neuroscience Letters 192 (1995) 121-123
8. He J.Q., Tang X.W., Chen H.X., and Xiang Z. Study on treatment of climacteric depression with bushen tiaogan qingxin recipe. Zhongguo Zhong Xi Yi Jie He Za Zhi 24 (2004) 889-892
9. Holsboer F., Gerken A., Stalla G.K., and Muller O.A. ACTH, cortisol and corticosterone output after ovine corticotrophin-releasing factor challenge during depression and after recovery. Biological Psychiatry 20 (1985) 276-286
10. Jiangsu College of New Medicine. The Dictionary of the Traditional Chinese Medicine (1977), Shanghai Press of Science & Technology, Shanghai 1177-1179
11. Kong L.D., Tan R.X., Woo A.Y., and Cheng C.H.K. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Pharmacology and Toxicology 88 (2001) 75-80
12. Kunugi H., Ida I., Owashi T., Kimura M., Inoue Y., Nakagawa S., Yabana T., Urushibara T., Kanai R., Aihara M., Yuuki N., Otsubo T., Oshima A., Kudo K., Inoue T., Kitaichi Y., Shirakawa O., Isogawa K., Nagayama H., Kamijima K., Nanko S., Kanba S., Higuchi T., and Mikuni M. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology 31 (2006) 212-220
13. Li Z., Kang S.S., Lee S., and Rivier C. Effect of ethanol on the regulation of corticotropin-releasing factor (CRF) gene expression. Molecular and Cellular Neuroscience 29 (2005) 345-354
14. Linkowski P., Mendlewicz J., LeClerc R., Brasseur M., Hubain P., Goldstein J., Copinschi G., and Van Cauter E. The 24-hour profile of ACTH and cortisol in major depressive illness. Journal of Clinical Endocrinology and Metabolism 61 (1985) 429-438
15. Luo H.C., Qian R.Q., Zhao X.Y., Bi J., Xin H., Jiang X., Xu K., and Yan S. Clinical observation on effect of danzhi xiaoyao powder in treating depression. Zhongguo Zhong Xi Yi Jie He Za Zhi 26 (2006) 212-214
16. Mantle F. The role of alternative medicine in treating postnatal depression. Complementary Therapies in Nursing and Midwifery 8 (2002) 197-203
17. Qiao C.F., Han Q.B., Mo S.F., Song J.Z., Xu L.J., Chen S.L., Yang D.J., Kong L.D., Kung H.F., and Xu H.X. Psoralenoside and isopsoralenoside, two new benzofuran glycosides from Psoralea corylifolia. Chemical and Pharmaceutical Bulletin 54 (2006) 714-716
18. Wu J., An H., Li Y., and Duan L. TCM treatment with the modified wendan tang in 40 cases of melancholia. Journal of Traditional Chinese Medicine 19 (1999) 296-297
19. Yi L.T., Li Y.C., Pan Y., Li J.M., Xu Q., Mo S.F., Qiao C.F., Jiang F.X., Xu H.X., Lu X.B., Kong L.D., and Kung H.F. Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea corylifolia in the forced swimming test in mice. Progress in Neuropsychopharmacology and Biological Psychiatry 32 (2008) 510-519